183 related articles for article (PubMed ID: 33954875)
1. Cumulative perioperative lymphocyte/C-reactive protein ratio as a predictor of the long-term outcomes of patients with colorectal cancer.
Okugawa Y; Toiyama Y; Fujikawa H; Kawamura M; Yasuda H; Yokoe T; Mochiki I; Okita Y; Ohi M; Nakatani K
Surg Today; 2021 Dec; 51(12):1906-1917. PubMed ID: 33954875
[TBL] [Abstract][Full Text] [Related]
2. Lymphocyte-C-reactive Protein Ratio as Promising New Marker for Predicting Surgical and Oncological Outcomes in Colorectal Cancer.
Okugawa Y; Toiyama Y; Yamamoto A; Shigemori T; Ide S; Kitajima T; Fujikawa H; Yasuda H; Hiro J; Yoshiyama S; Yokoe T; Saigusa S; Tanaka K; Shirai Y; Kobayashi M; Ohi M; Araki T; McMillan DC; Miki C; Goel A; Kusunoki M
Ann Surg; 2020 Aug; 272(2):342-351. PubMed ID: 32675548
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of the preoperative lymphocyte to C-reactive protein ratio in patients with stage III colorectal cancer.
Eren T
ANZ J Surg; 2022 Oct; 92(10):2585-2594. PubMed ID: 35779019
[TBL] [Abstract][Full Text] [Related]
4. Lymphocyte-to-C-reactive protein ratio and score are clinically feasible nutrition-inflammation markers of outcome in patients with gastric cancer.
Okugawa Y; Toiyama Y; Yamamoto A; Shigemori T; Ichikawa T; Yin C; Suzuki A; Fujikawa H; Yasuda H; Hiro J; Yoshiyama S; Ohi M; Araki T; McMillan DC; Kusunoki M
Clin Nutr; 2020 Apr; 39(4):1209-1217. PubMed ID: 31155370
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive Comparative Analysis of Prognostic Value of Systemic Inflammatory Biomarkers for Patients with Stage II/III Colon Cancer.
Suzuki S; Akiyoshi T; Oba K; Otsuka F; Tominaga T; Nagasaki T; Fukunaga Y; Ueno M
Ann Surg Oncol; 2020 Mar; 27(3):844-852. PubMed ID: 31720937
[TBL] [Abstract][Full Text] [Related]
6. Prognostic role and clinical significance of C-reactive protein-lymphocyte ratio in colorectal cancer.
Meng Y; Long C; Huang X; Huang L; Liao L; Tang W; Liu J
Bioengineered; 2021 Dec; 12(1):5138-5148. PubMed ID: 34436973
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of systemic inflammation and for patients with colorectal cancer cachexia.
Ruan GT; Xie HL; Yuan KT; Lin SQ; Zhang HY; Liu CA; Shi JY; Ge YZ; Song MM; Hu CL; Zhang XW; Liu XY; Yang M; Wang KH; Zheng X; Chen Y; Hu W; Cong MH; Zhu LC; Deng L; Shi HP
J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2813-2823. PubMed ID: 37902006
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Potential of Lymphocyte-C-Reactive Protein Ratio in Patients with Rectal Cancer Receiving Preoperative Chemoradiotherapy.
Okugawa Y; Toiyama Y; Fujikawa H; Ide S; Yamamoto A; Omura Y; Yin C; Kusunoki K; Kusunoki Y; Yasuda H; Yokoe T; Hiro J; Ohi M; Kusunoki M
J Gastrointest Surg; 2021 Feb; 25(2):492-502. PubMed ID: 32040814
[TBL] [Abstract][Full Text] [Related]
9. Clinical implications of the preoperative lymphocyte C-reactive protein ratio in esophageal cancer patients.
Yamamoto A; Toiyama Y; Okugawa Y; Ichikawa T; Imaoka H; Yasuda H; Fujikawa H; Okita Y; Yokoe T; Ohi M
Surg Today; 2021 May; 51(5):745-755. PubMed ID: 33130991
[TBL] [Abstract][Full Text] [Related]
10. The preoperative neutrophil to lymphocyte ratio is a superior indicator of prognosis compared with other inflammatory biomarkers in resectable colorectal cancer.
Song Y; Yang Y; Gao P; Chen X; Yu D; Xu Y; Zhao J; Wang Z
BMC Cancer; 2017 Nov; 17(1):744. PubMed ID: 29126400
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Significance of Preoperative Lymphocyte-to-C-Reactive Protein Ratio in Patients with Non-Metastatic Colorectal Cancer.
Ou W; Zhou C; Zhu X; Lin L; Xu Q
Onco Targets Ther; 2021; 14():337-346. PubMed ID: 33469310
[TBL] [Abstract][Full Text] [Related]
12. Preoperative lymphocyte/C-reactive protein ratio and its correlation with CD8
Miyazaki K; Morine Y; Imura S; Ikemoto T; Saito Y; Yamada S; Tokuda K; Okikawa S; Yamashita S; Oya T; Tsuneyama K; Shimada M
Surg Today; 2021 Dec; 51(12):1985-1995. PubMed ID: 34009433
[TBL] [Abstract][Full Text] [Related]
13. Association of nutritional risk and systemic inflammation with survival in patients with colorectal cancer who underwent curative surgery.
Nakamura Y; Imada A; Fukugaki A; Kanto S; Yamaura T; Kinjo Y; Kuroda N
Clin Nutr ESPEN; 2022 Jun; 49():417-424. PubMed ID: 35623847
[TBL] [Abstract][Full Text] [Related]
14. Cumulative C-reactive Protein in the Perioperative Period as a Novel Marker for Oncological Outcome in Patients with Colorectal Cancer Undergoing Curative Resection.
Fujikawa H; Okugawa Y; Yamamoto A; Imaoka H; Shimura T; Kitajima T; Kawamura M; Yasuda H; Okita Y; Yokoe T; Ohi M; Toiyama Y
J Anus Rectum Colon; 2021; 5(3):281-290. PubMed ID: 34395941
[TBL] [Abstract][Full Text] [Related]
15. Preoperative Absolute Lymphocyte Count to Carcinoembryonic Antigen Ratio Is a Superior Predictor of Survival in Stage I to III Colorectal Cancer.
Zhou Y; Cheng F; Zhang Z; Xiang J; Xue T; Ye Q; Yan B
Clin Med Insights Oncol; 2022; 16():11795549221126249. PubMed ID: 36186673
[TBL] [Abstract][Full Text] [Related]
16. Neutrophils to lymphocytes ratio as a useful prognosticator for stage II colorectal cancer patients.
Dimitriou N; Felekouras E; Karavokyros I; Alexandrou A; Pikoulis E; Griniatsos J
BMC Cancer; 2018 Dec; 18(1):1202. PubMed ID: 30509242
[TBL] [Abstract][Full Text] [Related]
17. Postoperative, but not preoperative, inflammation-based prognostic markers are prognostic factors in stage III colorectal cancer patients.
Yasui K; Shida D; Nakamura Y; Ahiko Y; Tsukamoto S; Kanemitsu Y
Br J Cancer; 2021 Mar; 124(5):933-941. PubMed ID: 33257844
[TBL] [Abstract][Full Text] [Related]
18. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
Song A; Eo W; Lee S
World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
[TBL] [Abstract][Full Text] [Related]
19. Correlation between Prognostic Nutritional Index, Glasgow Prognostic Score, Systemic Inflammatory Response, and TNM Staging in Colorectal Cancer Patients.
Bai X; Feng L
Nutr Cancer; 2020; 72(7):1170-1177. PubMed ID: 31630565
[No Abstract] [Full Text] [Related]
20. Increased platelet-lymphocyte ratio closely relates to inferior clinical features and worse long-term survival in both resected and metastatic colorectal cancer: an updated systematic review and meta-analysis of 24 studies.
Chen N; Li W; Huang K; Yang W; Huang L; Cong T; Li Q; Qiu M
Oncotarget; 2017 May; 8(19):32356-32369. PubMed ID: 28404961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
